Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

Best of ASCO GU 2016 prostate cancer data

Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson

Best of ASCO GU 2016 prostate cancer data ( Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson )

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )

Avelumab for metastatic urothelial carcinoma: JAVELIN trial

Dr Andrea Apolo - National Cancer Institute, Maryland, USA

Avelumab for metastatic urothelial carcinoma: JAVELIN trial ( Dr Andrea Apolo - National Cancer Institute, Maryland, USA )

Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC

Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA

Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )

Impact of metformin on outcomes for metastatic renal cell carcinoma

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA

Impact of metformin on outcomes for metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )

ASCO GU 2016: Highlights

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )

Atezolizumab for platinum-treated locally advanced or metastatic urothelial...

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )

Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer

Prof Eleni Efstathiou and Prof Nick James

Celecoxib with or without zoledronic acid for hormone-naïve prostate cancer ( Prof Eleni Efstathiou and Prof Nick James )

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

Survival outcomes from the CALGB 40603 study in triple-negative breast cancer

Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA

Survival outcomes from the CALGB 40603 study in triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )

TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer...

Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium

TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )

NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally...

Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA

NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer ( Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA )

More from ecancer